T-Cell Receptor Vα Spectratype Analysis of a CD4-Mediated T-Cell Response against Minor Histocompatibility Antigens Involved in Severe Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 8, 2006, Pages 818-827

  DiRienzo, Christine G ^b   Murphy, George F ^c   Jones, Stephen C ^b   Korngold, Robert ^a,b   Friedman, Thea M ^a,b  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Graft versus host disease; Minor histocompatibility antigens; Repertoire; T cell receptor; V alpha chain

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOHISTOCHEMISTRY; INOCULATION; INTESTINE EPITHELIUM; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; T LYMPHOCYTE; TONGUE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GRAFT VS HOST DISEASE; MALE; MICE; MINOR HISTOCOMPATIBILITY ANTIGENS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEVERITY OF ILLNESS INDEX;

EID: 33746101455     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.05.002     Document Type: Article

References (39)

1. Nikolich-Zugich J., Slifka M.K., and Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 4 (2004) 123-132
2. Argaet V.P., Schmidt C.W., Burrows S.R., et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med. 180 (1994) 2335-2340
3. Matsumoto Y., Yoon W.K., Jee Y., et al. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol. 170 (2003) 4846-4853
4. Friedman T.M., Statton D., Jones S.C., et al. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease. correlations with epithelial tissue infiltrate. Biol Blood Marrow Transplant. 7 (2001) 2-13
5. + T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease. correlations with epithelial tissue infiltrate. Biol Blood Marrow Transplant. 7 (2001) 2-13
6. Hirokawa M., Matsutani T., Saitoh H., et al. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation. Bone Marrow Transplant. 30 (2002) 915-923
7. Margolis D.A., Casper J.T., Segura A.D., et al. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant. 6 (2000) 408-415
8. Ferrara J.L., Levy R., and Chao N.J. Pathophysiologic mechanisms of acute graft-vs-host disease. Biol Blood Marrow Transplant. 5 (1999) 347-356
9. Kernan N.A., Collins N.H., Juliano L., et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 68 (1986) 770-773
10. Friedman T.M., Gilbert M., Briggs C., et al. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease. J Immunol. 161 (1998) 41-48
11. + T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens. Biol Blood Marrow Transplant. 10 (2004) 224-235
12. Jones S.C., Friedman T.M., Murphy G.F., et al. Specific donor Vβ-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens. Biol Blood Marrow Transplant. 10 (2004) 91-105
13. Patterson A.E., and Korngold R. Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines. Biol Blood Marrow Transplant. 6 (2000) 537-547
14. + T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 7 (2001) 187-196
15. Brandle D., Burki K., Wallace V.A., et al. Involvement of both T-cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition. Eur J Immunol. 21 (1991) 2195-2202
16. Engel I., and Hedrick S.M. Site-directed mutations in the VDJ junctional region of a T-cell receptor beta chain cause changes in antigenic peptide recognition. Cell 54 (1988) 473-484
17. Mantovani S., Palermo B., Garbelli S., et al. Dominant TCR-alpha requirements for a self-antigen recognition in humans. J Immunol. 169 (2002) 6253-6260
18. Yokosuka T., Takase K., Suzuki M., et al. Predominant role of T cell receptor (TCR)-alpha chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system. J Exp Med. 195 (2002) 991-1001
19. Matsutani T., Yoshioka T., Tsuruta Y., et al. Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation. Br J Haematol. 109 (2000) 759-769
20. Oksenberg J.R., Stuart S., Begovich A.B., et al. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature 353 (1991) 94
21. Reinherz E.L., Tan K., Tang L., et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286 (1999) 1913-1921
22. Turner S.J., Cose S.C., and Carbone F.R. TCR alpha-chain usage can determine antigen-selected TCR beta-chain repertoire diversity. J Immunol. 157 (1996) 4979-4985
23. Sarmiento M., Glasebrook A.L., and Fitch F.W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol. 125 (1980) 2665-2672
24. Bruce J., Symington F.W., McKearn T.J., et al. A monoclonal antibody discriminating between subsets of T and B cells. J Immunol. 127 (1981) 2496-2501
25. Gorski J., Yassai M., Zhu X., et al. Circulating T-cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. correlation with immune status. J Immunol. 152 (1994) 5109-5119
26. Casanova J.L., Romero P., Widmann C., et al. T-cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide. implications for T-cell allelic exclusion and antigen-specific repertoire. J Exp Med. 174 (1991) 1371-1383
27. Whitaker-Menezes D., Jones S.C., Friedman T.M., et al. An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression. Biol Blood Marrow Transplant. 9 (2003) 559-570
28. Korngold R., Jameson B.A., McDonnell J.M., et al. Peptide analogs that inhibit IgE-Fc epsilon RI alpha interactions ameliorate the development of lethal graft-versus-host disease. Biol Blood Marrow Transplant. 3 (1997) 187-193
29. Sale G.E., Raff R.F., and Storb R. Stem cell regions in filiform papillae of tongue as targets of graft-versus-host disease. Transplantation 58 (1994) 1273-1275
30. Gilliam A.C., Whitaker-Menezes D., Korngold R., et al. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol. 107 (1996) 377-383
31. Sim B.C., Lo D., and Gascoigne N.R. Preferential expression of TCR V alpha regions in CD4/CD8 subsets. class discrimination or co-receptor recognition?. Immunol Today 19 (1998) 276-282
32. Uematsu Y. Preferential association of alpha and beta chains of the T-cell antigen receptor. Eur J Immunol. 22 (1992) 603-606
33. Korngold R., Leighton C., Mobraaten L.E., et al. Interstrain graft-vs-host disease T-cell responses to immunodominant minor histocompatibility antigens. Biol Blood Marrow Transplant. 3 (1997) 57-64
34. el-Shami K., Tirosh B., Bar-Haim E., et al. MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope. Eur J Immunol. 29 (1999) 3295-3301
35. Kubo K., Yamanaka K., Kiyoi H., et al. Different T-cell receptor repertoires between lesions and peripheral blood in acute graft-versus-host disease after allogeneic bone marrow transplantation. Blood 87 (1996) 3019-3026
36. Griem P., Wallny H.J., Falk K., et al. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. Cell 65 (1991) 633-640
37. Miconnet I., de la Selle V., Tucek C., et al. Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR. Immunogenetics 39 (1994) 178-186
38. Wysocki C.A., Panoskaltsis-Mortari A., Blazar B.R., et al. Leukocyte migration and graft-versus-host disease. Blood 105 (2005) 4191-4199
39. Chiocchia G., Boissier M.C., and Fournier C. Therapy against murine collagen-induced arthritis with T-cell receptor V beta-specific antibodies. Eur J Immunol. 21 (1991) 2899-2905